Clinical Trial Update: Telmisartan, Amlodipine and Flow Mediated Dilation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating telmisartan and amlodipine on flow-mediated dilation in hypertension; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Hypertension | Phase 4 | Status: UNKNOWN